Alto Neuroscience, Inc. 8-K

What Happened

• On March 16, 2026, Alto Neuroscience, Inc. announced and reported its financial results for the fiscal year ended December 31, 2025. The company furnished a press release announcing those results as Exhibit 99.1 to its Current Report on Form 8-K (Item 2.02). The filing is signed by Amit Etkin, M.D., Ph.D., President and Chief Executive Officer.

Key Details

• Filing date: March 16, 2026 (Form 8-K filed with the SEC).
• Reporting period: fiscal year ended December 31, 2025.
• Press release: furnished as Exhibit 99.1 to the Form 8-K and incorporated by reference.
• Signature: report signed by Amit Etkin, President & CEO.

Why It Matters

• This 8-K signals that Alto has publicly released its FY2025 earnings and financial condition information — key data points investors use to assess revenue, expenses, cash position and operating trends.
• Retail investors should read the furnished press release (Exhibit 99.1) and the company’s subsequent SEC filings for the specific numbers (revenue, net income/loss, cash runway, and any management commentary or outlook) to understand how FY2025 results affect valuation and near-term expectations.